Business Context and Reporting Period
Company: InMed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 23, 2021
Reporting Period: Single event date (November 23, 2021)
Business Context: The company is an emerging growth company incorporated in British Columbia, Canada, with common shares traded on The Nasdaq Stock Market LLC under the symbol "INM".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations were reported in this filing. The document solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: InMed's management team is scheduled to participate in Cowen's 4th Annual Cannabis Conference.
- Event Dates: November 29 – December 1, 2021.
- Format: Virtual conference.
- Legal Disclaimer: Information furnished in this report (including Exhibit 99.1) is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific date and time of the management presentation at Cowen's 4th Annual Cannabis Conference.
- Review the accompanying news release (Exhibit 99.1) for any additional details regarding the presentation content.
- Confirm the company's status as an emerging growth company and its implications for financial reporting standards.
- Check subsequent filings for any financial updates or strategic announcements made during the conference.